• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Bemarituzumab Antibody – Human

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818601

Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Bemarituzumab, Antibody
Full Product Name
Bemarituzumab
Product Synonym Names
FPA144
Host
Human
Species Reactivity
FGFR2b
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1952272-74-0

Other Notes

Small volumes of anti-Bemarituzumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Bemarituzumab purchase

MBS5818601 is an antibody targeting Bemarituzumab. Reactive in FGFR2b. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000